Robotics to Be the Driving Force Behind J&J’s Device Unit

January 26, 2020 Digital Surgery, Johnson & Johnson, Medical Devices, Robotics

Johnson & Johnson is slated to offer a preview of its surgical robotics solution strategy in May during its Medical Device Business Review Day in New York.

Johnson & Johnson is offering a preview of its surgical robotics strategy May 13^thduring its Medical Device Business Review Day in New York. Executives of the New Brunswick, NJ-based company announced the date during a call discussing its 4Q19 results on Wednesday.

Alex Gorsky, J&J’s CEO noted that going forward surgical robotics would be a driving force behind the company’s medtech division.

“As it relates to medical devices, we’ve been, I think, very consistent in sharing our thinking that, again, this next generation is certainly about the robotics component that helps facilitate perhaps having more consistency in an exact procedure, perhaps getting into a tighter space, having better access,” Gorsky said, according to a Seeking Alpha transcript of the earnings call.

The news follows the healthcare giant buying out Verily’s interest in the Verb Surgical joint venture for an undisclosed sum. The Verb buyout is one of two major developments that occurred last year that are set to power J&J’s upcoming surgical robotics platform. The second development is J&J’s acquisition of Auris Health.

Redwood City, CA-based Auris Health develops robotic technologies that have been focused on lung cancer. The firm has the Monarch Platform, an FDA-cleared system currently used in bronchoscopic diagnostic and therapeutic procedures.

Gorsky spoke about how both Verb and Auris play into the May 13^th preview.

“We think combining Auris and Verb really helps ensure that we have a very strong role in the next-generation of the digital surgery platform and ongoing development,” Gorsky said according to a Seeking Alpha transcript of the earnings call. “Our teams are working now together in a really comprehensive way.

By Omar Ford | MD+DI

Image Credit: Omar Ford / MD+DI

READ MORE

About Peter Coffaro 510 Articles

Peter Coffaro is a growth-driven and strategic executive with over 25 years of progressive management success in the medical device industry. With a proven track record and recognized expertise, Peter has established himself as one of the top influencers in medical sales, as acknowledged by prestigious publications such as the World Journal of Orthopedics, Exponential Healthtech, and MedReps.com. Throughout his career, Peter has accumulated 10 years of combined sales management experience, excelling in various roles including Director, General Manager, Distributor, and Vice President. He has worked for industry-leading orthopedic companies such as Zimmer, DePuy, and Stryker, solidifying his deep knowledge and network within the field. Peter’s passion for innovation and emerging technologies led him to found OrthoFeed, an award-winning blog covering digital orthopedic news and emerging medical technologies. Through this platform, he stays at the forefront of the industry and contributes to the dissemination of valuable insights. Peter is a three-time Hall of Fame award winner at Johnson and Johnson, demonstrating his exceptional contributions and impact on the organization. His expertise extends to areas such as organizational development, business development, sales management, digital marketing, and professional education. Peter earned a B.S. degree in Biology and Chemistry from Northern Illinois University, further complementing his comprehensive understanding of the medical field. With his wealth of experience, strategic mindset, and dedication to advancing healthcare, Peter Coffaro is a valuable asset and leader in the medical device industry.